The ReBuilder was first registered by the FDA in 1988. Why is it not in mainstream medicine by now?
In reality, we don’t know! Rebuilder Medical is a small company (almost 20 employees, 10,000 square foot facility) and has a tough time as it is meeting increasing production demands. We are currently examining offers to take our company “public” to raise the necessary capital to increase our manufacturing capability and to fund marketing beyond the web.Most doctors simply do not have time to read all the published info available.Also, the ReBuilder was first introduced for peripheral artery disease alone, not for peripheral neuropathy. The founder, David B. Phillips, invented it to help his father rehabilitate after his open heart coronary artery bypass surgery. His father complained more from the leg incision (to remove the leg vein for grafting material) than from the chest incision. The ReBuilder enabled him to heal in 2 weeks and return to his normal life. He is now 82 and works full time at ReBuilder medical, Inc. The ReBuilder was re-engineered in 2001 for use in peripheral neur
